Stéphane Boissel
Director/Miembro de la Junta en ADOCIA .
Origen de la red de primer grado Stéphane Boissel.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Université Paris Dauphine-PSL
40
| College/University | Other Consumer Services | 40 |
The French Society of Financial Analysts
31
| College/University | Other Consumer Services | 31 |
| Public Company | Biotechnology | 23 | |
Lazard Group LLC
 Lazard Group LLC Investment ManagersFinance Lazard Group LLC provides financial advisory, asset management, and other financial services. The firm offers services related to mergers and acquisitions, strategic advisory, middle market advisory, capital markets and capital structure advisory, sovereign advisory, restructuring, and private fund advisory. The company was founded in 1840 and is headquartered in New York, NY.
18
| Subsidiary | Investment Managers | 18 |
SparingVision SAS
 SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France.
12
| Holding Company | Biotechnology | 12 |
11
| Public Company | Biotechnology | 11 |
11
| Public Company | Pharmaceuticals: Major | 11 |
| Public Company | Pharmaceuticals: Major | 11 | |
PricewaterhouseCoopers France SARL
 PricewaterhouseCoopers France SARL Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers France provides accounting and business management consulting services. It offers expertise in auditing, financial strategy, legal advise, and investment. The company was founded on May 30, 1963 and is headquartered in Neuilly-sur-Seine, France.
8
| Subsidiary | Miscellaneous Commercial Services | 8 |
ERYTech Pharma SA
 ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France.
6
| Extinct | Pharmaceuticals: Major | 6 |
EG 427
 EG 427 Miscellaneous Commercial ServicesCommercial Services EG 427 is a French biotechnology company that specializes in gene therapy. The location of the company is unknown. The company was founded by Alberto Epstein, François Giuliano, and Philippe O. Chambon, with Philippe O. Chambon serving as CEO since incorporation.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
| Subsidiary | Pharmaceuticals: Major | 4 | |
Transgene, Inc.
2
| Subsidiary | 2 | |
Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd.
2
| Subsidiary | 2 | |
Platine Pharma Services SAS
 Platine Pharma Services SAS Medical/Nursing ServicesHealth Services Based in Lyon within the Center of excellence in Infectious Diseases, Platine Pharma Services is an essential source of immune information for scientists and clinicians. From protocol support to regulatory reports, the company designs, performs and interprets complex molecular and cellular assays. Platine actively supports the development of in-vitro diagnostic, cosmetic and therapeutic product candidates, highlighting key markers and features in both normal and pathological conditions, and guiding decisions at each development stage. Using state-of-the-art technologies such as multi-parametric flow cytometry, Singulex, Luminex, Mesoscale Discovery, ELISpot or ELISA, Platine Pharma Services offers a fit-for-purpose approach to its customers and partners.
2
| Subsidiary | Medical/Nursing Services | 2 |
Genclis SA
 Genclis SA Miscellaneous Commercial ServicesCommercial Services Genclis SA operates as a holding company with interest in providing research services to the medical and biotechnology firms. The company was founded by Jean Cinqualbre in 2006 and is headquartered in Vandoeuvre-les-Nancy, France.
1
| Holding Company | Miscellaneous Commercial Services | 1 |
| Public Company | Investment Managers | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Stéphane Boissel a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| Sciences Po | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Institut Mérieux SA
 Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Secretary Corporate Officer/Principal | |
Advanced BioScience Laboratories, Inc.
 Advanced BioScience Laboratories, Inc. Medical/Nursing ServicesHealth Services Advanced BioScience Laboratories, Inc. provides contract manufacturing and laboratory research services to advance leading vaccines and therapies from clinical development to the commercial market. It focuses on the development of therapeutics, vaccines, and other biologic products. The company was founded in 1961 and is headquartered in Rockville, MD. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member Chairman | |
| NATIXIS | Investment Managers | Investor Relations Contact Corporate Officer/Principal Director/Board Member | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
Institut Français Des Administrateurs
 Institut Français Des Administrateurs Miscellaneous Commercial ServicesCommercial Services Institut Français Des Administrateurs is a private company based in Paris, France. The French company promotes governance and develops leadership skills. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BIOMÉRIEUX | Medical Specialties | Director/Board Member Director/Board Member Public Communications Contact | |
| University of Lyon | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| ESSEC Business School | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| Université Paris II Panthéon Assas | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
Association Lyon Place Financière
 Association Lyon Place Financière Miscellaneous Commercial ServicesCommercial Services Association Lyon Place Financière et Tertiaire operates as a business consortium, with interest in the promotion of regional financial development. Its advocacies cover the monitoring of competitivenes, risk, equity, shareholder relations, investment, and transparency. The company was founded by Roger Michaux, Raymond Barre, Régis Lagrevol, and Etienne Subra in 1986 and is headquartered in Lyon, France. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Ecole Polytechnique | College/University | Undergraduate Degree Undergraduate Degree | |
Fabentech SAS
 Fabentech SAS Medical/Nursing ServicesHealth Services Fabentech SAS developes immunotherapeutic solutions for emerging infectious diseases as well as for certain drug intoxications. Its products include infography development, Lassa(FBH-003) and other emerging diseases. The company was founded by Bertrand Lepine on June 5, 2009 and is headquartered in Lyon, France. | Medical/Nursing Services | Chairman Chairman | |
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
 Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. engages in theresearch and development, and manufacture of immunotherapies for the treatment of oncology and infectious diseases. Its business scope includes biopharmaceutical technology development, technology transfer, and related technical advisory services. The company was founded on July 26, 2010 and is headquartered in Tianjin, China. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
BioAster
 BioAster Miscellaneous Commercial ServicesCommercial Services BioAster operates as a research institute. The private company is based in Lyon, France. The CEO of the French company is Nathalie Garçon. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| Ecole Nationale de la Statistique & de l'Administration | College/University | Undergraduate Degree Undergraduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree | |
| École Nationale Supérieure des Mines de Paris | College/University | Undergraduate Degree Undergraduate Degree | |
| EURONEXT N.V. | Investment Banks/Brokers | Corporate Officer/Principal Director of Finance/CFO | |
Jalon Therapeutics
 Jalon Therapeutics Pharmaceuticals: MajorHealth Technology Jalon Therapeutics is a French company that aims to develop innovative therapies to treat cancer by inactivating vital tumor signaling pathways. Jalon Therapeutics is based in Paris, France and manages an extensive candidate portfolio of drug candidates infused by its unique expertise in AAC-11 biology. The company leverages their deep understanding of stress-related protein-protein interaction networks that sustain the malignant phenotype while not being necessary for normal cells. The company's lead candidate, JRT39, is the first-in-class drug developed for the treatment of hard-to-treat cancers. The company is building a drug discovery platform to develop other candidates derived from AAC-11 and AAC-11 partners for the treatment of cancer. Jalon Therapeutics raised a pre-seed in 2022, leveraged by non-dilutive and quasi-equity fundings from public institutions. The company's growth ambition is to raise a seed immediately followed by a series A to finance up to the clinical proof of concept of their lead candidate JRT39. The company was founded in 2021 by Jérôme Tiollier, Jean-Luc Poyet, Prof. Martine Bagot, Prof. Hervé Dombret, Jean-Christophe Rain, and Philippe Salphati. The CEO is David Loison. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| TXCELL | Miscellaneous Commercial Services | Director/Board Member General Counsel | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree | |
| CLARIANE SE | Medical/Nursing Services | Director/Board Member Director of Finance/CFO | |
| EUROSIC | Real Estate Investment Trusts | Director/Board Member Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
GPC Biotech, Inc.
 GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Drugstore Chains | Corporate Officer/Principal Corporate Officer/Principal | |
| GENEURO SA | Biotechnology | Director/Board Member Director/Board Member | |
| Columbia Business School | College/University | Undergraduate Degree Masters Business Admin | |
| Universite Paris Cite | College/University | Graduate Degree Doctorate Degree | |
| ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ICADE | Real Estate Development | Director/Board Member Director/Board Member | |
| ADVICENNE | Pharmaceuticals: Generic | Director of Finance/CFO Chief Executive Officer | |
| Université Claude Bernard Lyon 1 | College/University | Doctorate Degree Doctorate Degree | |
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Investor Private Equity Investor | |
iSTAR Medical SA
 iSTAR Medical SA Medical SpecialtiesHealth Technology iSTAR Medical SA develops innovative ophthalmic implants. Its products include MINIject, STARflo and STAR Material. The company was founded by Michel Alvarez in 2011 and is headquartered in Wavre, Belgium. | Medical Specialties | Director/Board Member Chief Executive Officer | |
CDC Croissance SA
 CDC Croissance SA Investment ManagersFinance CDC Croissance SA is an asset management firm headquartered in Paris, France. It was founded in 2001 as CDC Entreprises Valeurs Moyennes SAS. The firm is a subsidiary of BPIFrance Investissement, which in turn is a subsidiary of government-owned Caisse d'Amortissement de la Dette Sociale. CDC Croissance manages assets of individual and institutional clients. | Investment Managers | Chief Investment Officer Corporate Officer/Principal | |
| THERADIAG | Medical Specialties | Director/Board Member Investor Relations Contact | |
Sanofi Pasteur
 Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Biotechnology | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Emergence Therapeutics AG
 Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Pharmaceuticals: Major | Director/Board Member Chairman |
Estadísticas
Internacional
| Francia | 36 |
| Estados Unidos | 10 |
| Canadá | 2 |
| China | 2 |
| Países Bajos | 2 |
Sectorial
| Consumer Services | 18 |
| Health Technology | 17 |
| Finance | 9 |
| Commercial Services | 6 |
| Health Services | 4 |
Operativa
| Director/Board Member | 507 |
| Corporate Officer/Principal | 188 |
| Chairman | 103 |
| Independent Dir/Board Member | 81 |
| Chief Executive Officer | 77 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Magali Chessé | 69 |
| Jean-Luc Bélingard | 40 |
| Daniel Karyotis | 34 |
| Philippe Chambon | 31 |
| Joseph Papa | 28 |
| Vincent Bazi | 26 |
| Philippe Archinard | 24 |
| Agnès Tixier | 24 |
| Sven Arne Andréasson | 24 |
| Dominique Takizawa | 23 |
| Sundar Kodiyalam | 21 |
| Laurent Arthaud | 21 |
| Ekaterina Smirnyagina | 21 |
| David Lamond | 20 |
| Virginie Cayatte | 20 |
- Bolsa de valores
- Insiders
- Stéphane Boissel
- Conexiones Empresas
